Upgrade to SI Premium - Free Trial

Sapiens Reports Second Quarter 2019 Financial Results

August 5, 2019 4:49 AM

HOLON, Israel, Aug. 5, 2019 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ: SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, and a member of the Formula Group (NASDAQ: FORTY) (TASE: FORT), today announced its financial results for the second quarter ended June 30, 2019.

Sapiens Logo

Summary Results for Second Quarter 2019 (USD in millions, except per share data)

GAAP

% Change

Non-GAAP

% Change

June 30, 2019

June 30, 2018

June 30, 2019

June 30, 2018

Revenue

$79.5

$72.2

10.2%

$79.5

$72.5

9.6%

Gross Profit

$31.5

$26.9

17.1%

$34.8

$30.4

14.3%

Gross Margin

39.6%

37.2%

240 bps

43.8%

42.0%

180 bps

Operating Income

$9.5

$4.9

91.8%

$12.6

$9.6

31.4%

Operating Margin

11.9%

6.8%

510 bps

15.8%

13.2%

260 bps

Net income (*)

$6.8

$2.0

239.6%

$9.5

$6.4

49.5%

Diluted EPS

$0.14

$0.04

236%

$0.19

$0.13

45.4%

(*) Attributable to Sapiens' shareholders

"Sapiens priorities for 2019 are growth and margin expansion. In the second quarter we delivered on both of these goals. Top line non-GAAP revenue increased 9.6% and non-GAAP operating margin improved 260 basis points. Growth and profitability in the quarter tie directly to executing on our key objectives to win new customers, cross sell to existing customers, leverage our offshore capabilities, and scale revenue over our efficient cost structure. Our improving margins support our build-out of sales and customer support teams and our investment in our offshore capabilities, particularly in India. As we head into the second half of the year, our sustained performance gives us confidence that our strategy is working, and we are dedicated to further improving shareholder value through long-term, sustainable growth." said Roni Al-Dor, president and CEO, Sapiens.

"Looking out to the remainder of 2019, I'm encouraged by our pipeline of business and anticipate annual growth of over 10%. We are forecasting non-GAAP revenue in a range of $318 - $323 million, however we now expect revenues to be on the higher end of this range" concluded Roni Al-Dor. "The increase in revenue and the leverage from improved economies of scale allows us to increase the guidance for non-GAAP operating margin in a range of 15.6% - 15.8%, compared to our previous guidance of 15.2% - 15.6%"

Quarterly Results Conference Call

Management will host a conference call and webcast on August 5, 2019 at 9:30 a.m. Eastern Time (4:30 p.m. in Israel) to review and discuss Sapiens' results.

Please call the following numbers (at least 10 minutes before the scheduled time) to participate:

North America (toll-free): + 1-888-668-9141; International: +972-3- 9180610; UK: 0-800-917-5108

The live webcast of the call can be viewed on Sapiens' website at: https://www.sapiens.com/investor-relations/ir-events-presentations/

If you are unable to join live, a replay of the call will be accessible until August 13, 2019, as follows:

North America: 1-877-456-0009; International: +972-3-925-5921

A recorded version of the webcast will also be available via the Sapiens website, for three months at the same location.

Non-GAAP Financial Measures

This press release contains the following non-GAAP financial measures: non-GAAP revenue, non-GAAP gross profit, non-GAAP operating income, non-GAAP net income attributed to Sapiens shareholders, non-GAAP basic and diluted earnings per share, Adjusted EBITDA and Adjusted Free Cash-Flow.

Sapiens believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Sapiens' financial condition and results of operations. The Company's management uses these non-GAAP measures to compare the Company's performance to that of prior periods for trend analyses, for purposes of determining executive and senior management incentive compensation and for budgeting and planning purposes. These measures are used in financial reports prepared for management and in quarterly financial reports presented to the Company's board of directors. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends, and in comparing the Company's financial measures with other software companies, many of which present similar non-GAAP financial measures to investors.

Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: Valuation adjustment on acquired deferred revenue, amortization of capitalized software development and other intangible assets, capitalization of software development, stock-based compensation, restructuring and cost reduction costs, tax adjustments related to non-GAAP adjustments, and acquisition-related costs, which pertain to charges on behalf of M&A agreements related to future performance targets and retention criteria as determined upon acquisition date of the respective acquired company, as well as third-party services, such as, tax, accounting and legal rendered until the acquisition date.

Management of the Company does not consider these non-GAAP measures in isolation, or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company's financial statements. In addition, they are subject to inherent limitations, as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures.

To compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. Sapiens urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company's business.

Reconciliation tables of the most comparable GAAP financial measures to the non-GAAP financial measures used in this press release are included with the financial tables of this release.

The Company defines Adjusted EBITDA as net profit, adjusted for valuation adjustment on acquired deferred revenue, stock-based compensation expense, depreciation and amortization, capitalized of software development costs, compensation expenses related to acquisition and acquisition-related costs, restructuring and cost reduction costs, financial expense (income), provision for income taxes and other income (expenses). These amounts are often excluded by other companies to help investors understand the operational performance of their business.

The Company uses Adjusted EBITDA as a measurement of its operating performance, and reconciles Non-GAAP Operating Income to Adjusted EBITDA, adjusted for amortization and capitalization of capitalized software and amortization other intangible assets, stock-based compensation and acquisition-related costs, and valuation adjustment on acquired deferred revenues. The Company uses Adjusted EBITDA, because it assists in comparing the operating performance on a consistent basis by removing the impact of certain non-cash and non-operating items. Adjusted EBITDA reflects an additional way of viewing aspects of the operations that the Company believes, when viewed with the GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provide a more complete understanding of factors and trends affecting its business.

The Company uses Adjusted Free Cash-Flow as a measurement of its operating performance, and reconciles cash-flow from operating activities to Adjusted Free Cash-Flow while reducing the amounts for capitalization of software development costs and capital expenditures, and adds back cash payments made for former acquisitions in respect of future performance targets and retention criteria as determined upon acquisition date of the respective acquired company, and were included in the cash-flow from operating activities. We believe that Adjusted Free Cash-Flow is useful in evaluating our business, because Adjusted Free Cash-Flow reflects the cash surplus available to fund the expansion of our business.

About Sapiens

Sapiens International Corporation empowers insurers to succeed in an evolving industry. The company offers digital software platforms, solutions and services for the property and casualty, life, pension and annuity, reinsurance, financial and compliance, workers' compensation and financial markets. With more than 35 years of experience delivering to over 450 organizations globally, Sapiens has a proven ability to satisfy customers' core, data and digital requirements. For more information: www.sapiens.com

Forward Looking Statement

Some of the statements in this press release may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities and Exchange Act of 1934 and the United States Private Securities Litigation Reform Act of 1995. Words such as "will," "expects," "believes" and similar expressions are used to identify these forward-looking statements (although not all forward-looking statements include such words). These forward-looking statements, which may include, without limitation, projections regarding our future performance and financial condition, are made on the basis of management's current views and assumptions with respect to future events. Any forward-looking statement is not a guarantee of future performance and actual results could differ materially from those contained in the forward-looking statement.

These statements speak only as of the date they were made, and we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. We operate in a changing environment. New risks emerge from time to time and it is not possible for us to predict all risks that may affect us. For more information regarding these risks and uncertainties, as well as certain additional risks that we face, please refer to the Risk Factors detailed in Item 3 of Part III of our Annual Report on Form 20-F for the year ended December 31, 2018, and subsequent reports and registration statements filed from time to time with the Securities and Exchange Commission.

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

U.S. dollars in thousands (except per share amounts)

Three months ended

Six months ended

June 30

June 30

2019

2018

2019

2018

(unaudited)

(unaudited)

(unaudited)

(unaudited)

Revenue

79,529

72,164

156,316

143,159

Cost of revenue

48,075

45,305

95,055

89,272

Gross profit

31,454

26,859

61,261

53,887

Operating expenses:

Research and development, net

8,923

8,633

17,700

17,780

Selling, marketing, general and administrative

13,077

13,298

26,030

26,482

Total operating expenses

22,000

21,931

43,730

44,262

Operating income

9,454

4,928

17,531

9,625

Financial expense, net

434

1,316

1,488

2,154

Taxes and other expenses, net

2,154

1,483

4,001

2,514

Net income

6,866

2,129

12,042

4,957

Attributable to non-controlling interest

26

115

47

107

Net income attributable to Sapiens' shareholders

6,840

2,014

11,995

4,850

Basic earnings per share

0.14

0.04

0.24

0.10

Diluted earnings per share

0.14

0.04

0.24

0.10

Weighted average number of shares outstanding used to compute basic earnings per share (in thousands)

50,002

49,785

49,994

49,779

Weighted average number of shares outstanding used to compute diluted earnings per share (in thousands)

50,530

49,998

50,430

50,033

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED NON-GAAP STATEMENTS OF INCOME

U.S. dollars in thousands (except per share amounts)

Three months ended

Six months ended

June 30

June 30

2019

2018

2019

2018

(unaudited)

(unaudited)

(unaudited)

(unaudited)

Revenue

79,529

72,542

156,316

143,627

Cost of revenue

44,735

42,105

88,418

82,906

Gross profit

34,794

30,437

67,898

60,721

Operating expenses:

Research and development, net

10,493

9,926

20,662

20,250

Selling, marketing, general and administrative

11,720

10,936

22,905

22,033

Total operating expenses

22,213

20,862

43,567

42,283

Operating income

12,581

9,575

24,331

18,438

Financial expense, net

434

1,316

1,488

2,154

Taxes and other expenses

2,580

1,762

4,865

3,488

Net income

9,567

6,497

17,978

12,796

Attributable to non-controlling interest

26

115

47

107

Net income attributable to Sapiens' shareholders

9,541

6,382

17,931

12,689

Basic earnings per share

0.19

0.13

0.36

0.25

Diluted earnings per share

0.19

0.13

0.36

0.25

Weighted average number of shares outstanding used to compute basic earnings per share (in thousands)

50,002

49,785

49,994

49,779

Weighted average number of shares outstanding used to compute diluted earnings per share (in thousands)

50,530

49,998

50,430

50,033

SAPIENS INTERNATIONAL CORPORATION N.V. AND SUBSIDIARIES

RECONCILIATION OF GAAP TO NON-GAAP RESULTS

U.S. dollars in thousands (except per share amounts)

Three months ended

Six months ended

June 30,

June 30,

2019

2018

2019

2018

(unaudited)

(unaudited)

(unaudited)

(unaudited)

GAAP revenue

79,529

72,164

156,316

143,159

Valuation adjustment on acquired deferred revenue

-

378

-

468

Non-GAAP revenue

79,529

72,542

156,316

143,627

GAAP gross profit

31,454

26,859

61,261

53,887

Valuation adjustment on acquired deferred revenue

-

378

-

468

Amortization of capitalized software

1,390

1,152

2,731

2,407

Amortization of other intangible assets

1,950

2,048

3,906

3,959

Non-GAAP gross profit

34,794

30,437

67,898

60,721

GAAP operating income

9,454

4,928

17,531

9,625

Gross profit adjustments

3,340

3,578

6,637

6,834

Capitalization of software development

(1,570)

(1,293)

(2,962)

(2,470)

Amortization of other intangible assets

540

706

1,075

1,628

Stock-based compensation

288

499

741

1,086

Acquisition-related costs *)

529

1,157

1,309

1,735

Non-GAAP operating income

12,581

9,575

24,331

18,438

GAAP net income attributable to Sapiens' shareholders

6,840

2,014

11,995

4,850

Operating income adjustments

3,127

4,647

6,800

8,813

Tax and other

(426)

(279)

(864)

(974)

Non-GAAP net income attributable to Sapiens' shareholders

9,541

6,382

17,931

12,689

(*) Acquisition-related costs pertain to charges on behalf of M&A agreements related to future performance targets and retention criteria, as well as third-party services, such as, tax, accounting and legal rendered until the acquisition date.

Summary of NON-GAAP Financial Information

U.S. dollars in thousands (except per share amounts)

Q2 2019

Q1 2019

Q4 2018

Q3 2018

Q2 2018

Revenues

79,529

76,787

73,433

73,237

72,542

Gross profit

34,794

33,104

31,320

30,903

30,437

Operating income

12,581

11,750

10,849

10,273

9,575

Net income to Sapiens' shareholders

9,541

8,390

7,826

7,548

6,382

Adjusted EBITDA

13,358

12,524

11,797

11,236

10,385

Basic earnings per share

0.19

0.17

0.16

0.15

0.13

Diluted earnings per share

0.19

0.17

0.16

0.15

0.13

Non-GAAP Revenues by Geographic Breakdown

U.S. dollars in thousands

Q2 2019

Q1 2019

Q4 2018

Q3 2018

Q2 2018

North America

39,216

38,149

34,974

36,734

34,606

Europe

33,881

32,193

30,850

30,611

32,518

Asia Pacific

3,515

3,670

3,140

3,480

3,305

South Africa

2,917

2,775

4,469

2,412

2,113

Total

79,529

76,787

73,433

73,237

72,542

Adjusted Free Cash-Flow

U.S. dollars in thousands

Q2 2019

Q1 2019

Q4 2018

Q3 2018

Q2 2018

Cash-flow from operating activities

15,507

10,550

11,509

6,370

658

Increase in capitalized software

development costs

(1,570)

(1,392)

(1,382)

(1,308)

(1,293)

Capital expenditures

(1,079)

(641)

(204)

(831)

(402)

Free cash-flow

12,858

8,517

9,923

4,231

(1,037)

Cash payments attributed to acquisition-related costs(*) (**)

1,692

1,608

790

-

256

Adjusted free cash-flow

14,550

10,125

10,713

4,231

(781)

(*) Included in cash-flow from operating activities

(**) Acquisition-related payments pertain to payments on behalf of M&A agreements related to future performance targets and retention criteria, as well as third-party services, such as, tax, accounting and legal rendered until the acquisition date.

Adjusted EBITDA Calculation

U.S. dollars in thousands

Three months ended

Six months ended

June 30

June 30

2019

2018

2019

2018

GAAP operating profit

9,454

4,928

17,531

9,625

Non-GAAP adjustments:

Amortization of capitalized software

1,390

1,152

2,731

2,407

Amortization of other intangible assets

2,490

2,754

4,981

5,587

Capitalization of software development

(1,570)

(1,293)

(2,962)

(2,470)

Stock-based compensation

288

499

741

1,086

Acquisition-related costs

529

1,157

1,310

1,735

Valuation adjustment on acquired deferred revenue

-

378

-

468

Non-GAAP operating profit

12,581

9,575

24,332

18,438

Depreciation

777

810

1,550

1,892

Adjusted EBITDA

13,358

10,385

25,882

20,330

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

U.S. dollars in thousands

June 30,

December 31,

2019

2018

(unaudited)

(unaudited)

ASSETS

CURRENT ASSETS

Cash and cash equivalents

77,282

64,628

Trade receivables, net and unbilled receivables

58,827

59,159

Other receivables and prepaid expenses

7,615

6,224

Total current assets

143,724

130,011

LONG-TERM ASSETS

Property and equipment, net

9,264

8,515

Severance pay fund

4,941

4,699

Goodwill and intangible assets, net

230,069

231,348

Operating lease right-of-use assets

54,106

-

Other long-term assets

4,885

4,292

Total long-term assets

303,265

248,854

TOTAL ASSETS

446,989

378,865

LIABILITIES AND EQUITY

CURRENT LIABILITIES

Trade payables

6,491

6,149

Current maturities of Series B Debentures

9,898

9,898

Accrued expenses and other liabilities

49,390

46,999

Current maturities of operating lease liabilities

8,107

-

Deferred revenue

22,782

18,057

Total current liabilities

96,668

81,103

LONG-TERM LIABILITIES

Series B Debentures, net of current maturities

58,763

68,577

Deferred tax liabilities

9,692

11,681

Other long-term liabilities

7,723

9,398

Long-term operating lease liabilities

48,105

-

Accrued severance pay

5,946

5,622

Total long-term liabilities

130,229

95,278

EQUITY

220,092

202,484

TOTAL LIABILITIES AND EQUITY

446,989

378,865

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONSOLIDATED STATEMENT OF CASH FLOW

U.S. dollars in thousands

For the six months ended June 30,

2019

2018

(unaudited)

(unaudited)

Cash flows from operating activities:

Net income

12,042

4,957

Reconciliation of net income (loss) to net cash provided by operating

activities:

Depreciation and amortization

9,262

9,886

Accretion of discount on Series B Debentures

84

94

Capital gain from sale of property and equipment

(129)

-

Stock-based compensation related to options issued to employees

741

1,086

Net changes in operating assets and liabilities, net of amount acquired:

Trade receivables, net and unbilled receivables

712

(2,416)

Deferred tax assets

(1,435)

(300)

Other operating assets

(356)

(886)

Trade payables

190

(4,853)

Other operating liabilities

152

(4,691)

Deferred revenues

4,760

6,888

Severance pay

34

56

Net cash provided by operating activities

26,057

9,821

Cash flows from investing activities:

Purchase of property and equipment

(1,720)

(879)

Investment in deposit

(1,119)

-

Payments for business acquisition, net of cash acquired

-

(18,203)

Proceeds from sale of property and equipment

821

-

Capitalized software development costs

(2,962)

(2,470)

Net cash used in investing activities

(4,980)

(21,552)

Cash flows from financing activities:

Proceeds from employee stock options exercised

78

128

Repayment of Series B Debentures

(9,898)

-

Repayment of loan

(4)

(27)

Payment of contingent considerations

(120)

(61)

Dividend to non-controlling interest

(66)

(47)

Net cash provided by financing activities

(10,010)

(7)

Effect of exchange rate changes on cash and cash equivalents

1,587

(522)

Increase (decrease) in cash and cash equivalents

12,654

(12,260)

Cash and cash equivalents at the beginning of period

64,628

71,467

Cash and cash equivalents at the end of period

77,282

59,207

Debentures Covenants

As of June 30, 2019, Sapiens was in compliance with all of its financial covenants under the indenture for the Series B Debentures that it issued in September 2017, based on having achieved the following in its consolidated financial results:

Covenant 1

  • Target shareholders' equity (excluding minority interest): above $120 million.
  • Actual shareholders' equity equal to $219 million.

Covenant 2

  • Target ratio of net financial indebtedness to net capitalization (in each case, as defined under the indenture for the Company's Series B Debentures) below 65%.
  • Actual ratio of net financial indebtedness to net capitalization equal to -3.51%.

Covenant 3

  • Target ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is below 5.5.
  • Actual ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is equal to -0.15.

Investors and Media Contact Yaffa Cohen-Ifrah Chief Marketing Officer and Head of Corporate Communications Sapiens International U.S. Mobile: +1-201-250-9414 Mobile: +972 54-9099039 Email: [email protected]

Cision View original content:http://www.prnewswire.com/news-releases/sapiens-reports-second-quarter-2019-financial-results-300896181.html

SOURCE Sapiens International Corporation

Categories

PRNewswire Press Releases

Next Articles